Eastman Chemical Company (EMN) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $73.79. It has a SharesGrow Score of 52/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of EMN = $142.41 (+93% from the current price, the stock appears undervalued). Analyst consensus target is EMN = $74 (-0.3% upside).
Valuation: EMN trades at a trailing Price-to-Earnings (P/E) of 17.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.25.
Financials: revenue is $8.8B, -5.9%/yr average growth. Net income is $474M, growing at -11.2%/yr. Net profit margin is 5.4% (thin). Gross margin is 21.1% (+0.9 pp trend).
Balance sheet: total debt is $5.1B against $6.0B equity (Debt-to-Equity (D/E) ratio 0.85, moderate). Current ratio is 1.37 (adequate). Debt-to-assets is 34.2%. Total assets: $14.9B.
Analyst outlook: 20 / 35 analysts rate EMN as buy (57%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 67/100 (Pass), Growth 15/100 (Fail), Past 100/100 (Pass), Health 50/100 (Partial), Moat 49/100 (Partial), Future 38/100 (Fail), Income 45/100 (Partial).
